Skip to main content
Advertisement
Advertisement

XGN

XGN logo

Exagen Inc. Common Stock

8.74
USD
Sponsored
+0.19
+2.22%
Sep 24, 15:59 UTC -4
Closed
exchange

Pre-Market

8.67

-0.07
-0.84%

XGN Earnings Reports

Positive Surprise Ratio

XGN beat 22 of 28 last estimates.

79%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$18.53M
/
-$0.18
Implied change from Q2 26 (Revenue/ EPS)
-7.09%
/
+38.46%
Implied change from Q3 25 (Revenue/ EPS)
+7.44%
/
-41.94%

Exagen Inc. Common Stock earnings per share and revenue

On Aug 04, 2026, XGN reported earnings of -0.13 USD per share (EPS) for Q2 26, beating the estimate of -0.19 USD, resulting in a 32.26% surprise. Revenue reached 19.94 million, compared to an expected 18.00 million, with a 10.81% difference. The market reacted with a +37.82% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -0.18 USD, with revenue projected to reach 18.53 million USD, implying an increase of 38.46% EPS, and decrease of -7.09% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-$0.62
Actual
-$0.65
Surprise
-3.47%
logo
High Tide Inc. Common Shares
Report Date
Sep 14, 2026 For Q3 26
Estimate
$0.01
Actual
$0.12
Surprise
+1,088.12%
FAQ
For Q2 2026, Exagen Inc. Common Stock reported EPS of -$0.13, beating estimates by 32.26%, and revenue of $19.94M, 10.81% above expectations.
The stock price moved up 37.82%, changed from $4.68 before the earnings release to $6.45 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 9 analysts, Exagen Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $18.53M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement